https://www.diabesityrounds.com/a/network-meta-analysis-sglt2-inhibitors-versus-finerenone-in-ckd-with-type-2-diabDiabesity Roundsen2026-10-13T20:03:56.190ZNetwork meta-analysis: SGLT2 inhibitors versus finerenone in CKD with type 2 diabeteshttps://www.diabesityrounds.com/a/meta-analysis-sglt2-inhibitors-reduce-heart-failure-or-cv-death-in-type-2-diabetDiabesity Roundsen2026-10-13T20:02:18.237ZMeta-analysis: SGLT2 inhibitors reduce heart failure or CV death in type 2 diabetes